de Abreu Sesconetto Lucas, da Silva Rafael Benjamim Rosa, Galletti Ricardo Purchio, Agareno Gabriel Andrade, Colonno Barbara Buccelli, de Sousa Jorge Henrique Bento, Tustumi Francisco
Department of Surgery, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Department of Gastroenterology, Universidade de São Paulo, São Paulo, Brazil.
Obes Surg. 2023 Feb;33(2):600-610. doi: 10.1007/s11695-022-06382-5. Epub 2022 Dec 1.
This systematic review aims to compare the accuracy of pre-existent scores predicting diabetes remission after bariatric and metabolic surgery. Among the scores, DiaBetter presented the largest area under the curve (AUC) (0.87; 95% CI, 0.84-0.9). Ad-DiaRem had the lowest AUC (0.79; 95% CI, 0.76-0.83). Ad-DiaRem showed the highest sensitivity (91%; 95% CI, 86-96%), with a specificity of 71.23% (95% CI 50.43 to 92.06%). IMS showed a sensitivity of 59% (95% CI, 20-90%), with the highest specificity (86%; 95% CI, 69-94%). Clinicians should associate the findings of the present review with patients' individual characteristics to help predict diabetes remission and evaluate the probability of the patient benefit from surgery.
本系统评价旨在比较预测减肥和代谢手术后糖尿病缓解的现有评分的准确性。在这些评分中，DiaBetter的曲线下面积（AUC）最大（0.87；95%置信区间，0.84 - 0.9）。Ad - DiaRem的AUC最低（0.79；95%置信区间，0.76 - 0.83）。Ad - DiaRem的敏感性最高（91%；95%置信区间，86 - 96%），特异性为71.23%（95%置信区间50.43至92.06%）。IMS的敏感性为59%（95%置信区间，20 - 90%），特异性最高（86%；95%置信区间，69 - 94%）。临床医生应将本评价的结果与患者的个体特征相结合，以帮助预测糖尿病缓解情况并评估患者从手术中获益的可能性。
